Agnello, F.; Laterra, G.; Scalia, L.; Mauro, M.S.; Strazzieri, O.; Reddavid, C.; Ingala, S.; Guarino, S.; Barbera, C.; Russo, M.D.;
et al. Lipoprotein(a) and Aortic Valve Stenosis: From Pathophysiology to Emerging Pharmacological Agents. J. Clin. Med. 2026, 15, 274.
https://doi.org/10.3390/jcm15010274
AMA Style
Agnello F, Laterra G, Scalia L, Mauro MS, Strazzieri O, Reddavid C, Ingala S, Guarino S, Barbera C, Russo MD,
et al. Lipoprotein(a) and Aortic Valve Stenosis: From Pathophysiology to Emerging Pharmacological Agents. Journal of Clinical Medicine. 2026; 15(1):274.
https://doi.org/10.3390/jcm15010274
Chicago/Turabian Style
Agnello, Federica, Giulia Laterra, Lorenzo Scalia, Maria Sara Mauro, Orazio Strazzieri, Claudia Reddavid, Salvatore Ingala, Simona Guarino, Chiara Barbera, Maria Daniela Russo,
and et al. 2026. "Lipoprotein(a) and Aortic Valve Stenosis: From Pathophysiology to Emerging Pharmacological Agents" Journal of Clinical Medicine 15, no. 1: 274.
https://doi.org/10.3390/jcm15010274
APA Style
Agnello, F., Laterra, G., Scalia, L., Mauro, M. S., Strazzieri, O., Reddavid, C., Ingala, S., Guarino, S., Barbera, C., Russo, M. D., & Barbanti, M.
(2026). Lipoprotein(a) and Aortic Valve Stenosis: From Pathophysiology to Emerging Pharmacological Agents. Journal of Clinical Medicine, 15(1), 274.
https://doi.org/10.3390/jcm15010274
